T Weinreich

Summary

Affiliation: Nephrological Center
Country: Germany

Publications

  1. ncbi Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients
    Thomas Weinreich
    Nephrologisches Zentrum, Villingen Schwenningen, Germany
    Hemodial Int 16:11-9. 2012
  2. ncbi Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients
    T Weinreich
    Nephrologisches Zentrum Villingen Schwenningen, Germany
    Clin Nephrol 66:433-9. 2006

Detail Information

Publications2

  1. ncbi Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients
    Thomas Weinreich
    Nephrologisches Zentrum, Villingen Schwenningen, Germany
    Hemodial Int 16:11-9. 2012
    ..Once-monthly CERA therapy maintains stable Hb values with low intra-individual variability and few dose adaptations in hemodialysis patients when administered entirely according to local practice, and the regimen was well-tolerated...
  2. ncbi Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients
    T Weinreich
    Nephrologisches Zentrum Villingen Schwenningen, Germany
    Clin Nephrol 66:433-9. 2006
    ....